Abstract
COR-101 is a fully human, Fc silenced IgG that was discovered by antibody phage display. It reduced the SARS-CoV-2 virus load in the lung by more than 99 percent in Hamster models and led to much faster recovery. Its mode of action has been elucidated by solving the atomic structure of its interaction with SARS-CoV-2. The antibody competes with ACE2 binding by blocking a large area of the SARS-CoV-2 spike protein.
The content is available as a PDF (487.8 KB).
Funding note
Open Access funding enabled and organized by Projekt DEAL.
Literatur
- [1].Menachery VD, Yount BL, Debbink K, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2015;21:1508–1513. doi: 10.1038/nm.3985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894–904. doi: 10.1016/j.cell.2020.03.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Frenzel A, Kügler J, Helmsing S, et al. Designing human antibodies by phage display. Transfus Med Hemother. 2017;44:312–318. doi: 10.1159/000479633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Froude JW, Herbert AS, Pelat T, et al. Postexposure protection in mice against sudan virus by a two antibody cocktail. Viruses. 2018;10:286. doi: 10.3390/v10060286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Burke CW, Froude JW, Miethe S, et al. Human-like neutralizing antibodies protect mice from aerosol exposure with western equine encephalitis virus. Viruses. 2018;10:147. doi: 10.3390/v10040147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Froude JW, Pelat T, Miethe S, et al. Generation and characterization of protective antibodies to Marburg virus. mAbs. 2017;9:696–703. doi: 10.1080/19420862.2017.1299848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Bertoglio F, Meier D, Langreder N et al. (2020) SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun, im Druck [DOI] [PMC free article] [PubMed]
- [9].Bertoglio F, Fühner V, Ruschig M et al. (2020) A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to known RBD mutations. Nat Commun, im Druck, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754550 [DOI] [PMC free article] [PubMed]
- [10].Dübel S, Hust M, Frenzel A, et al. Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19. BIOspektrum. 2020;4:44–446. doi: 10.1007/s12268-020-1404-4. [DOI] [PMC free article] [PubMed] [Google Scholar]